2 tracked superinvestors hold INCYTE CORP (INCY), worth $407M combined, led by ex-Jim Simons. Smart money is holding INCY as of the latest 13F filings.
Current price
$118.52
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor…
Market cap
$19.4B
P/E
13.69
Div yield
0.0%
Revenue YoY
21.2%
Analyst target
$109
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$407M
disclosed long exposure
Tier-1 conviction
0
concentrated holders
Net this quarter
0
1 buying · 1 selling
Smart money is holding INCY steady this quarter — buys and sells are balanced.
INCYTE CORP (INCY) appears mainly in diversified and quant books here (2 funds, $407M combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.
The largest position belongs to ex-Jim Simons at 0.5% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 1 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 0.5% | $344M | |
| Added | 0.2% | $64M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own INCY?
2 tracked funds hold INCYTE CORP (INCY), the largest being ex-Jim Simons (Renaissance Technologies) at 0.5% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling INCY?
In the most recent 13F quarter, 1 tracked fund added or opened INCY and 1 trimmed it.
How much INCY do tracked funds hold?
Combined disclosed long exposure to INCY across tracked superinvestors is $407M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.